DGS Capital Management »

Takeda Pharmaceutical shares owned by DGS Capital Management

Quarter-by-quarter ownership of Takeda Pharmaceutical (TAK) shares owned by DGS Capital Management from 13F filings

Historical chart of DGS Capital Management investment in Takeda Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Takeda Pharmaceutical held by DGS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Takeda Pharmaceutical by DGS Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $148k 11k 13.24

More positions owned by DGS Capital Management

Coinbase Global Inc Com Cl A Stock (COIN)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Meta Platforms Inc Cl A Stock (META)
Ishares Global Equity Factor Etf Etf (GLOF)
Amazon Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Celestica Stock (CLS)
Vanguard S&p 500 Etf Etf (VOO)
Taiwan Semiconductor Mfg Adr (TSM)
Sk Telecom Adr (SKM)
Eli Lilly & Co Stock (LLY)

View all positions for DGS Capital Management

Top funds holding Takeda Pharmaceutical

Capital Research Global Investors
Morgan Stanley
UBS Group
Goldman Sachs Group
FMR
Brandes Investment Partners
Renaissance Technologies
BlackRock
Toronto-Dominion Bank
Arrowstreet Capital, Limited Partnership
Millennium Management
First Trust Advisors
Northern Trust
Qube Research & Technologies
Citadel Advisors

View all funds holding Takeda Pharmaceutical